logo
How This 26-Year-Old Rescued A Failing Real Estate Startup—And Landed $58 Million From Google Ventures

How This 26-Year-Old Rescued A Failing Real Estate Startup—And Landed $58 Million From Google Ventures

Forbes3 days ago
Think this is nice? It's a version of the weekly Under 30 newsletter and would be even better in your inbox .
Din Bisevac and his team at Buena. Photo by Daniel Farò
Two years after Din Bisevac joined German real estate startup Buena as a product designer, the company—which was focused on leasing properties—had burned through $14 million. A shutdown seemed inevitable.
But on Thursday, Buena announced a $58 million Series A round led by Google Ventures, with backing from 20VC and Stride. It's the first raise since Bisevac stepped into the role of CEO in 2021.
'The original business model was kind of rent arbitrage. They would rent apartments at below market and try to rent them out above market,' the Under 30 Europe alum told Forbes . 'I spent the first year just restructuring, finding a good deal with the existing investors and basically pivoting the company.'
Today, Buena has reinvented itself as a Berlin-based software startup offering property management tools for landlords. The platform works with property owners to automate everything from listing properties and managing viewings to vetting tenants and coordinating maintenance, right down to scheduling a handyman or janitor. As of June, it's managing more than 60,000 apartments across Germany and has hit $25 million in annual recurring revenue.
Most of Buena's clients are private individuals—your typical apartment building owners—but the company has recently begun working with institutional investors managing hundreds of units.
'Property management just has a terrible, terrible brand in Germany. No matter which owner or tenant you ask, everyone will tell you they hate their property manager,' Bisevac says of the inspiration for the pivot. Still, with many clients used to the old-school way of doing things, he adds: 'We wouldn't position ourselves as this mainly technology company in front of our customers because it's a bit too abstract for them, and frankly just doesn't matter too much.'
Bisevac may have been thrust into the CEO seat, but he's no stranger to entrepreneurship. Before 'content creator' was even a term, the now-26-year-old was one of Germany's earliest YouTube child stars, hosting a Jimmy Fallon-style talk show on his channel. By age nine, he'd launched his own clothing brand, which he says gained traction with his followers. After his parents made him quit the online fame, he built a Shopify site for the business. Soon after, a local IT firm hired him as a product designer, at just 13 years old, and he began homeschooling.
He might regret stepping away from his internet stardom given the recent boom of the creator economy, but Bisevac is putting those same storytelling skills to work with Buena. His goal: make property ownership accessible to the younger generation—something like Robinhood for real estate.
'Our generation invests in ETFs, stocks, crypto, but we're missing the residential real estate part in our investment portfolios because we don't know how to do it,' he says. 'The broader vision with Buena is to become this end-to-end platform for people where you come to us to find an apartment you like, you buy it through us, we finance it for you, we manage it for you.'
For now, the new funding will fuel expansion across Germany, with plans to land in the U.S. next, where the housing market is valued at some $50 trillion.
More next week,
Zoya, Alex and Alexandra Can A Chatbot Be Your Therapist? Casper's Neil Parikh Launches A New $93 Million-Backed Startup To Try
Daniel Cahn (left) and Neil Parikh (right), cofounders of Slingshot AI. courtesy of slingshot
Neil Parikh's first startup, Casper, made sleep as easy as clicking a few buttons and getting a mattress delivered to your door. Now he wants to make getting therapy just as accessible. Parikh's latest venture, Slingshot AI, launched a chatbot that's designed to replicate the experience of talking to a human therapist. Can it work, and why not just use ChatGPT, if so? Find out more here. On Our Radar
-It's been six months since tens of thousands of federal employees began losing jobs due to DOGE budget cuts. What was meant to streamline the government and increase efficiency quickly turned into confusion and chaos across many federal agencies. "DOGE started to make itself known, it became a very strange, paranoid, alienating experience," Egan Reich, who resigned from his Department of Labor position in April, told Business Insider. "It became clear they really wanted people gone." He's not the only one with bitter feelings. ( Business Insider )
-Are we living amidst the second coming of Tyler Haney? The Outdoor Voices founder and 2016 Under 30 Retail & Ecommerce alum—who was ousted in 2020 and went on to build two other companies: TYB, a web 3 platform; and Joggy, a sports drink—is seemingly back in the drivers seat. The startup deleted all TikTok and Instagram posts and now follows just one Instagram account: @ty_haney. ( Inc. )
-Gen Z is looking for community, and they know the office is one place to get it. While it's true that only 6% of the young cohort prefers to work from the office all the time (only millennials are more opposed, with just 4% preferring in-office), they're actually the most likely to want to come in at least sometimes . 71% of Gen Zers say hybrid is their ideal environment. The loneliness they feel while WFH, plus the inability to learn from more experienced coworkers, appear to be major reasons. ( Gallup ) One Minute with Autumn-Kyoko Cushman
We're bringing you the scoop on a new Under 30 community member. Up this week: 2025 Under 30 Healthcare lister Autumn-Kyoko Cushman, cofounder of ShiftRx—a digital marketplace that connects healthcare facilities with clinicians to fill staffing gaps.
The following has been lightly edited for length and clarity.
How did you get the inspiration for ShiftRx? My cofounder and I were burned-out clinicians. I spent five years in the Navy as a nurse, working 12-hour clinical shifts during the height of the COVID-19 pandemic. Eventually, I left and began researching cancer clinical trials at the National Institutes of Health. After that, I thought I was ready to leave healthcare until my mom was diagnosed with a rare form of brain cancer. Even with my healthcare connections, advocating for her as a patient was a nightmare. That experience made me realize how broken the system really is and I got pissed off.
I quit my job, liquidated my savings, and roped in my best friend Leann, who was working as a pharmacy tech at CVS at the time. We knew someone had to address the staffing crisis, and we thought, 'Why not us?'
What's one lesson you would go back and tell yourself when first starting as a founder? You are capable of doing anything. It is definitely rooted in delusion. Leann and I genuinely believed we could fix healthcare as two 27-year-olds. The older you get, the more you realize that no one really knows what they're doing. We didn't have all the answers, but we had passion—and that was enough to start.
What's one thing you can't live without? My assistant Ashley. I love her—she's so freaking funny and keeps me sane. I stole her from another company five years ago, and she's by far my most valuable employee. When I'm in and out of meetings, working 100- to 120-hour weeks and barely sleeping or eating, she's the one taking care of me. She's the lock screen on my phone. I just love her. I also can't live without my AirPods.
What does a day in your life currently look like? I get out of bed, make my bed, go on a 30-minute walk, and then do a 45-minute run—usually while calling Ashley, who briefs me on my day. Then I get on the phone with my cofounder. I like taking calls while running because it keeps me running longer. After that, I make breakfast and head into the office.
I try to front-load all my meetings between 8 a.m. and 3 p.m.—I'm usually in 40 to 60 hours of meetings a week. I do my deep work between 4 p.m. and 10 p.m. with a brief intermission for dinner. I end the day with stretching and 20 to 30 minutes of reading—whether it's a book, article, newsletter or clinical research paper.
What's your favorite AI tool? I'm addicted to Superhuman, which is basically AI for emails. The instant intros and predictive text features are fantastic.
What's something on your bucket list? I'd love to swim with orcas. There's a Norwegian university that runs expeditions studying how orcas interact with humans in their natural environments, and I'm desperate to go. I could talk for 30 minutes about how intelligent and fascinating they are.
Who is someone—dead or alive—that you would love to have coffee with? Anna Wintour. She's such a trailblazer and forward thinker, taking Vogue from the print to the '.com' era. She's also just a genius, setting these cyclical fashion trends that move with the times. She's not in my industry, but I think it's so cool to learn from people that are incredible operators in their own industries.
What does ShiftRx's next chapter look like? The next chapter looks like fixing healthcare operations, improving patient outcomes, and automating tasks clinicians shouldn't have to worry about. We're stepping into the next phase of AI-native applications to improve the patient experience—making sure clinicians can focus solely on patient care.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025
Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

Yahoo

time2 hours ago

  • Yahoo

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for cancer, today announced that an abstract featuring the latest data from a Phase I/II study of the Claudin 18.2 antibody-drug conjugate (ADC), ATG-022, has been accepted for poster presentation at the 2025 European Society for Medical Oncology Annual Congress (ESMO 2025), taking place from October 17th to October 21st at the Messe Berlin in Berlin, Germany. Details of the Poster Presentation: ATG-022 (Claudin 18.2 antibody-drug conjugate)Title: Phase I/II study of Claudin 18.2 ADC ATG-022 in patients with advanced gastric/ gastroesophageal junction cancer (CLINCH)Abstract Number: 2907Presentation Number: 2113PDate: October 19, 2025 About ATG-022 ATG-022 is an antibody-drug conjugate (ADC) designed to target CLDN18.2, a member of the Claudin family of cell adhesion molecules. Under normal conditions, Claudins are located within tight junctions between cells, forming a barrier to regulate cell permeability. However, in cancer, Claudins are aberrantly expressed on the cell surface due to changes in cell polarity. CLDN18.2 is frequently overexpressed in a range of primary malignant tumors, including gastric, esophageal, cholangiocarcinoma, and pancreatic cancers. The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designations to ATG-022, for gastric and pancreatic cancers. Data from the ongoing CLINCH study demonstrated that ATG-022 delivers robust efficacy across all levels of CLDN18.2 expression in gastric cancer patients, including those with high, low, and ultra-low expression. This broad activity positions ATG-022 as a potential market leader, capable of addressing the largest patient population with CLDN18.2-positive tumors. Furthermore, the strong efficacy observed in patients with low CLDN18.2 expression suggests promise for treating other tumor types with similar expression profiles. About Antengene Antengene Corporation Limited ("Antengene", SEHK: is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of "Treating Patients Beyond Borders". Antengene has built a pipeline of 9 oncology assets at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region. To date, Antengene has obtained 31 investigational new drug (IND) approvals in the U.S. and Asia, and submitted new drug applications (NDAs) in 11 Asia Pacific markets, with the NDA for XPOVIO® (selinexor) already approved in Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia. Forward-looking statements The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company's Annual Report for the year ended December 31, 2024, and the documents subsequently submitted to the Hong Kong Stock Exchange. For more information, please contact: Investor Contacts: Donald LungE-mail: Mobile: +86 18420672158 PR Contacts:Peter QianE-mail: Mobile: +86 13062747000 View original content to download multimedia: SOURCE Antengene Corporation Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Walmart launches plan to steal customers away from Target, Amazon
Walmart launches plan to steal customers away from Target, Amazon

Miami Herald

time4 hours ago

  • Miami Herald

Walmart launches plan to steal customers away from Target, Amazon

If you're looking for a deal, you probably think to wait until the holidays, when most retailers launch big Black Friday sales. This is a sound idea; the holiday shopping season remains the most lucrative time of the year for most retailers. Related: Walmart cracks down on a growing type of fraud But the back-to-school shopping season is kind of like Black Friday's little sister. "The back-to-school shopping period from July to mid-September is the second-biggest sales driver of the year after the holiday season," the U.S. Chamber of Commerce reports. Every year, usually in the weeks that lead up to late August or early September, most big-box retail stores hold their own versions of back-to-school sales. It may seem gimmicky to celebrate a pretty routine part of the year to get shoppers through the door, but it works. "Americans are expected to spend $38.8 billion on clothes and supplies for children in grades K-12, and $86.6 billion on college students," the U.S. Chamber of Commerce said, per a 2024 National Retail Federation report. But tariffs, rising prices, and inflation complicate this picture. Many families have indicated they'll either slow their spending or specifically shop at discount retailers in search of deals. Some retailers, like Walmart (WMT) , are poised to win in such an environment. Image Source: Jones/Bloomberg via Getty Images The late summertime is typically a busy shopping period for Walmart. Customers are shopping for vacation, outdoor activities, picnics, and barbecues. And the most prepared ones begin to trickle in around mid-July for back-to-school shopping. More Retail: Walmart makes drastic change to fight theft amid worrying trendTarget has new plan to win back customers with big savingsHome Depot makes clear statement amid boycott threatsFamous retail chain makes two more alarming store closures So Walmart has decided to roll back the cost of some crucial items for families. The Arkansas-based retailer has cut the price of its top 14 most popular items to prices lower than they were one year prior. Some items are as low as $0.25, and its popular private brand Wonder Nation backpack is less than $5 at just $4.98. All told, Walmart says a student can get outfitted for the new year for just $65. But tariffs, which are duties on imported goods, have complicated the typically profitable back-to-school shopping period. Walmart CEO Doug McMillon explained the complication during the Q1 2026 earnings call. "We started to see increases happen in April and through May. We've been really focused on back-to-school receipts," McMillon explained. "When you have an imported item, you pay the tariff at the time it comes through customs. And so the cost is higher, even if the tariff rate comes down later, the cost has been elevated. McMillon added that tariffs could touch certain items, including back-to-school supplies, with an outsized effect. "So I wouldn't think of this as a moment in time necessarily, except when you think about seasonal things like back-to-school." Other top retailers, including Target (TGT) and Amazon (AMZN) , are also hosting early back-to-school promotions. Amazon's Prime Day served as its early back-to-school launch. It featured deals on books, notebooks, and pens for as low as $3. And Target announced it would put over 20 items on sale for back-to-school. The Minnesota-based retailer said it was freezing the prices of these items at 2024 prices. It claims students can bundle most of their school essentials for just around $20. The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Trump and EU reach trade deal ahead of looming deadline
Trump and EU reach trade deal ahead of looming deadline

USA Today

time5 hours ago

  • USA Today

Trump and EU reach trade deal ahead of looming deadline

The trade deal echoes the arrangement Trump reached with Japan. President Donald Trump announced July 27 the United States had reached a trade deal with the European Union, days ahead of a self-imposed Aug. 1 deadline. Trump met with the European Commission's president, Ursula von der Leyen, during his trip to Scotland over the weekend, where the pair discussed terms and came to an agreement. The deal includes a 15% tariff on most European exports to the United States, similar to agreements struck recently between Trump and other major trading partners, including Japan. The levy is higher than the 10% rate sought by Europeans but a reduction from the 30% Trump threatened to impose earlier in July. The agreement also includes $600 billion in EU investments in the U.S., and the purchase of $750 billion worth of U.S. energy. "I think we both wanted to make a deal,' Trump said. "I think it's going to be great for both.' The 15% tariff will be applied 'across the board,' for items including cars, but steel and aluminum will remain at 50%. "We have a trade deal between the two largest economies in the world, and it's a big deal,' von der Leyen said. 'It's a huge deal. It will bring stability. It will bring predictability.' The president has repeatedly criticized the European Union, saying it was "formed to screw the United States" on trade. The U.S. trade deficit with the EU reached $235 billion in 2024, according to U.S. Census Bureau data. Heading into the weekend meeting, he called the relationship between the EU and the United States "very unfair" and said he thought officials had a "50/50 chance" of striking a deal. After an agreement was announced, von der Leyen said the deal would "rebalance" relations, despite European leaders long claiming there was not an unfair trade balance. German Chancellor Friedrich Merz said the agreement averted a trade conflict that threatened a 27.5% tariff on cars. "This agreement has succeeded in averting a trade conflict that would have hit the export-orientated German economy hard,' Merz said. Italy's Prime Minister Giorgia Meloni called it a 'positive' trade deal. Ireland's Trade Minister Simon Harris said the tariff provides certainty in trade that 'is essential for jobs, growth and investment.' "A deal provides a measure of much needed certainty for Irish, European and American businesses who together represent the most integrated trading relationship in the world,' Harris said. Trump is seeking to reorder the global economy and reduce decades-old U.S. trade deficits. He has so far reeled in agreements with Britain, Japan, Indonesia and Vietnam, although his administration has failed to deliver on a promise of "90 deals in 90 days." The EU deal echoes the deal reached with Japan. Despite the recent deals, Commerce Secretary Howard Lutnick said the administration will continue to pursue aggressive tariffs around the world, including potential duties on critical semiconductors in the near future. Contributing: USA TODAY, Reuters

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store